Zacks Investment ResearchTue, 16 Jun 2026 17:02:24 GMTWave Life Sciences (WVE) Upgraded to Buy: Here's WhyWVE-1.49%
Seeking AlphaMon, 08 Jun 2026 14:58:32 GMTWave Life Sciences Ltd. (WVE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptWVE-1.49%
Seeking AlphaWed, 20 May 2026 17:21:11 GMTWave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD DataWVE-1.49%
Seeking AlphaTue, 19 May 2026 05:50:43 GMTWave Life Sciences Ltd. (WVE) Shareholder/Analyst Call TranscriptWVE-1.49%
Zacks Investment ResearchTue, 28 Apr 2026 13:46:16 GMTWave Life Sciences (WVE) Reports Q1 Loss, Beats Revenue EstimatesWVE-1.49%
The Motley FoolWed, 01 Apr 2026 20:45:00 GMTIs This Weight Loss Drug Stock a Buy on the Dip?WVE-1.49%
Zacks Investment ResearchWed, 01 Apr 2026 08:21:05 GMTWave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains?WVE-1.49%
Seeking AlphaFri, 27 Mar 2026 20:15:55 GMTWave Life Sciences Ltd. (WVE) Discusses Positive Interim Phase I Data from INLIGHT Trial of WVE-007 for Obesity TranscriptWVE-1.49%
Zacks Investment ResearchFri, 27 Mar 2026 16:25:14 GMTWVE Posts Interim Data From Phase I Study on WVE-007, Stock TanksWVE-1.49%
24/7 Wall StreetFri, 27 Mar 2026 14:00:35 GMTWave Life Sciences Slips as Obesity Data Fails to ConvinceWVE-1.49%
